Brief: Biosergen Announces Outcome Of Exercise Of Warrants Series TO2
28/08/2023 14:47
Aug 28 (Reuters) - Biosergen AB BIOSGN.ST :
* WARRANTS SERIES TO2 WERE EXERCISED TO APPROXIMATELY 96.1
PERCENT
AND BIOSERGEN AB RECEIVES APPROXIMATELY SEK 5.5 MILLION
* SUBSCRIPTION OF 8,258,203 SHARES AT AN EXERCISE PRICE OF
SEK
0.66 PER SHARE
Source text for Eikon: ID:nWkr98jMvC
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosergen AB
See all newsBrief: Nasdaq Approves Biosergen's Delisting Application
Brief: Biosergen Applies For Delisting Of The Company's Shares From Nasdaq First North Growth Market Conditional Upon Completion Of The Merger With Flerie
Brief: Biosergen Resolves On Set-Off Issue
Brief: Biosergen Rights Issue Oversubscribed
Brief: Biosergen Reports H1 EBITDA Of SEK -10.5 Million